investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Mechanism of Activity of Lonidamine

Jerry D Glickson

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Andrew Halestrap

University of Bristol

Bristol, United Kingdom

Jerry D Glickson

University of Pennsylvania

Philadelphia, United States

Related projects

Carl D Novina

(PQD1) Evolution of Vemurafenib Resistance in Circulating Melanoma Cells

Melanoma of skin

Pathology

William W Bachovchin

Using FAP to Selectively Target Epithelial Cancers

Melanoma of skin

Pathology

Ann Ager

Dissecting the impact of L-selectin on T lymphocyte dependent tumour immunity

Melanoma of skin

Pathology

Mel Greaves

Evolutionary biology of cancer

Melanoma of skin

Pathology

Akil Hamza

Human complementation of yeast mutations to identify candidate cancer therapeutic targets

Melanoma of skin All cancers but non-melanoma skin cancer

Ken Chen

Delineating Heterogeneous Structural Complexity in Cancer Genomes

Melanoma of skin All cancers but non-melanoma skin cancer

Jason Moffat

CRC Tier 2 - Identify novel cancer cell vulnerabilities

Melanoma of skin All cancers but non-melanoma skin cancer

Charles P. Lin

(PQC2) Localization as a determinant of cancer dormancy

Melanoma of skin All cancers but non-melanoma skin cancer

Alan Mak

The tumor suppressors, p53 and PTEN, are also suppressors of vascular smooth muscle cell migration and invasion.

Melanoma of skin All cancers but non-melanoma skin cancer